BioSpace News Archive

Gain Therapeutics SA announced that together with Dr. Maurizio Molinari from the Institute for Research in Biomedicine, Bellinzona (Switzerland) affiliated to the Università della Svizzera italiana (USI) and Neuro-Sys SAS in Gardanne (France), it has received funding support from Eurostars-2 joint programme with co-funding from the European Union Horizon 2020 research and Innosuisse – Swiss Innovation Agency.

JNDA Submission Represents First Regulatory Submission for Marketing Approval of Vadadustat

Global Provider Continues to Expand Product Portfolio

USPTO continues to award U.S. CRISPR-Cas9 patents to UC with four issued this month; eight this year; 10 overall; 15 by end of summer

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced financial results for the second quarter ended June 30, 2019.

BD, a leading global medical technology company, issued its 2018 Sustainability Report, focusing on management of the environmental, social and governance factors that support the company’s 2020 Sustainability Goals.

Proteostasis Therapeutics, Inc. announced the appointment of Geoffrey S. Gilmartin, M.D., M.M.Sc., as its Chief Medical Officer (CMO), and Andrey E. Belous, M.D., Ph.D., as a Senior Medical Director, effective August 5, 2019.

Crescendo Biologics Ltd announces that Takeda Pharmaceutical Company Limited, has exercised a second option under its existing, multi-target collaboration and license agreement.

Invitae Corporation, a leading medical genetics company, announced that it will report its second quarter 2019 financial results on Tuesday, August 6, 2019 and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.

European Patent Office Approves Core Patent Covering Soliton’s RAP Technology